Luzon, Mary Ann A.
HRN: 22-30-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/27/2022
IV
1.5
Single
LTCS
Waiting Final Action
12/27/2022
CEFUROXIME 500MG (TAB)
12/27/2022
01/02/2023
PO
500
BID
Repeat LSCS
Waiting Final Action